Citi downgraded Integra LifeSciences (NASDAQ: IART) from Buy to Neutral with a price target of $66.00 (from $64.00).Analyst Amit Hazan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE